Table 1.
Baseline characteristics of the study population.
| ICH Group (n = 2567) |
No-ICH Group (n = 47,983) |
p-Value * | |
|---|---|---|---|
| Age, median [25–75th percentile] | 69 [60–76] | 69 [59–75] | 0.017 |
| Sex, n (%) | 0.07 | ||
| Male | 1543 (60.1) | 29,723 (61.9) | |
| Female | 1024 (39.9) | 18,260 (38.1) | |
| Comorbidities, n (%) | |||
| Hypertension | 1704 (66.4) | 29,700 (61.9) | <0.001 |
| Diabetes mellitus | 848 (33.0) | 15,152 (31.6) | 0.19 |
| Dyslipidemia | 1149 (44.8) | 20,639 (43.0) | 0.09 |
| Acute myocardial infarction | 85 (3.3) | 1274 (2.7) | 0.052 |
| Congestive heart failure | 617 (24.0) | 9163 (19.1) | <0.001 |
| Atrial fibrillation | 540 (21.0) | 7003 (14.6) | <0.001 |
| Peripheral vascular disease | 403 (15.7) | 7525 (15.7) | 1.00 |
| Ischemic stroke | 374 (14.6) | 7283 (15.2) | 0.42 |
| Hemorrhagic stroke | 0 (0) | 350 (0.7) | <0.001 |
| Chronic kidney disease | 95 (3.7) | 1489 (3.1) | 0.10 |
| Liver cirrhosis | 20 (0.8) | 457 (1.0) | 0.44 |
| Cancer | 233 (9.1) | 3962 (8.3) | 0.15 |
| COPD | 169 (6.6) | 2878 (6.0) | 0.24 |
* The Wilcoxon rank-sum test was used for continuous variables. The chi-squared test was used for categorical variables. ICH, intracerebral hemorrhage; COPD, chronic obstructive pulmonary disease.